From the Editor's Desk

A Proven Model to Combat U.S. Drug Shortages

Drug shortages continue to plague the United States. In many ways, the problem is the result of deficiencies in the current pharma market. But a model for addressing this problem is showing that it isn’t intractable. The company employing this model is Civica Rx, which was established in 2018 by health systems and philanthropies to address shortages of generic sterile injectable drug. This article discusses the elements of its model and its achievements.

Continued here

TradeBriefs: Newsletters for Decision-Makers!

Our advertisers help fund the daily operations of TradeBriefs. We request you to accept our promotional emails.

Want the newsletters, without the promotional mailers?
Get an (ad-free) subscription to TradeBriefs Premium for just $1 per month.